SP3 and breast cancer: Moreover, treatment of penfluridol with A549 cells did not inhibit or slightly enhanced the expression of Sp1, Sp3, and Sp4 (Fig. S6), suggesting the underlying mechanisms involved in the anticancer action of penfluridol in NSCLC and breast cancer are different.